company background image
SBS logo

Stratec XTRA:SBS 주식 보고서

최종 가격

€28.85

시가총액

€350.7m

7D

-10.1%

1Y

-35.7%

업데이트

18 Nov, 2024

데이터

회사 재무 +

Stratec SE

XTRA:SBS 주식 보고서

시가총액: €350.7m

SBS 주식 개요

Stratec SE는 자회사와 함께 독일, 유럽 연합 및 전 세계에서 체외 진단 및 생명 과학 분야의 자동화 및 계측 솔루션을 설계하고 제조합니다. 자세한 내용

SBS 기본 분석
눈송이 점수
가치 평가3/6
미래 성장4/6
과거 실적1/6
재무 상태4/6
배당금4/6

보상

공정 가치 추정치보다 낮은 47.4% 에서 거래

수익은 매년 25.38% 증가할 것으로 예상됩니다.

1.91% 의 안정적인 배당금을 지급합니다.

분석가들은 주가가 42.1% 상승할 것이라는 데 동의합니다.

위험 분석

부채비율이 높네요


Stratec SE 경쟁사

Drägerwerk KGaA

XTRA:DRW3

€792.7m

PULSION Medical Systems

MUN:PUS

€134.4m

Eckert & Ziegler

XTRA:EUZ

€795.9m

Carl Zeiss Meditec

XTRA:AFX

€5.2b

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Stratec
과거 주가
현재 주가€28.85
52주 최고치€48.60
52주 최저치€28.40
베타0.23
11개월 변경-30.23%
3개월 변경 사항-34.06%
1년 변경 사항-35.75%
33년 변화-79.42%
5년 변화-56.29%
IPO 이후 변화454.49%

최근 뉴스 및 업데이트

With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Nov 09
With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Oct 26
Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Recent updates

With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Nov 09
With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Oct 26
Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

May 11
Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Apr 11
Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Apr 01
Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

Mar 28
Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Dec 21
Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Nov 03
Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Oct 19
We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Return Trends At Stratec (ETR:SBS) Aren't Appealing

Jul 12
Return Trends At Stratec (ETR:SBS) Aren't Appealing

Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 27
Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Is Stratec (ETR:SBS) Using Too Much Debt?

May 25
Is Stratec (ETR:SBS) Using Too Much Debt?

Stratec's (ETR:SBS) Upcoming Dividend Will Be Larger Than Last Year's

Apr 02
Stratec's (ETR:SBS) Upcoming Dividend Will Be Larger Than Last Year's

The Returns At Stratec (ETR:SBS) Aren't Growing

Jan 28
The Returns At Stratec (ETR:SBS) Aren't Growing

Calculating The Fair Value Of Stratec SE (ETR:SBS)

Jan 12
Calculating The Fair Value Of Stratec SE (ETR:SBS)

Is Stratec (ETR:SBS) A Risky Investment?

Oct 26
Is Stratec (ETR:SBS) A Risky Investment?

Returns On Capital At Stratec (ETR:SBS) Have Stalled

Oct 11
Returns On Capital At Stratec (ETR:SBS) Have Stalled

Stratec (ETR:SBS) Has A Pretty Healthy Balance Sheet

Jul 23
Stratec (ETR:SBS) Has A Pretty Healthy Balance Sheet

Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Jul 07
Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Stratec's (ETR:SBS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 12
Stratec's (ETR:SBS) Shareholders Will Receive A Bigger Dividend Than Last Year

Stratec (ETR:SBS) Has Announced That It Will Be Increasing Its Dividend To €0.95

Apr 28
Stratec (ETR:SBS) Has Announced That It Will Be Increasing Its Dividend To €0.95

Analysts Are Updating Their Stratec SE (ETR:SBS) Estimates After Its Annual Results

Apr 03
Analysts Are Updating Their Stratec SE (ETR:SBS) Estimates After Its Annual Results

Stratec's (ETR:SBS) Dividend Will Be Increased To €0.95

Apr 02
Stratec's (ETR:SBS) Dividend Will Be Increased To €0.95

These 4 Measures Indicate That Stratec (ETR:SBS) Is Using Debt Reasonably Well

Mar 13
These 4 Measures Indicate That Stratec (ETR:SBS) Is Using Debt Reasonably Well

Stratec (ETR:SBS) Is Doing The Right Things To Multiply Its Share Price

Feb 12
Stratec (ETR:SBS) Is Doing The Right Things To Multiply Its Share Price

Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Jan 27
Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

We Think Stratec (ETR:SBS) Can Stay On Top Of Its Debt

Dec 05
We Think Stratec (ETR:SBS) Can Stay On Top Of Its Debt

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Nov 02
Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Oct 18
Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Is Stratec (ETR:SBS) Using Too Much Debt?

Sep 03
Is Stratec (ETR:SBS) Using Too Much Debt?

Stratec (ETR:SBS) Will Want To Turn Around Its Return Trends

Aug 03
Stratec (ETR:SBS) Will Want To Turn Around Its Return Trends

Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Jul 20
Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Calculating The Intrinsic Value Of Stratec SE (ETR:SBS)

Jun 14
Calculating The Intrinsic Value Of Stratec SE (ETR:SBS)

Here's Why Stratec (ETR:SBS) Can Manage Its Debt Responsibly

May 31
Here's Why Stratec (ETR:SBS) Can Manage Its Debt Responsibly

주주 수익률

SBSDE Medical EquipmentDE 마켓
7D-10.1%-3.7%-0.5%
1Y-35.7%-4.2%8.3%

수익률 대 산업: SBS 지난 1년 동안 -4.2 %를 반환한 German Medical Equipment 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: SBS 지난 1년 동안 8.3 %를 반환한 German 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is SBS's price volatile compared to industry and market?
SBS volatility
SBS Average Weekly Movement4.9%
Medical Equipment Industry Average Movement5.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.0%
10% least volatile stocks in DE Market2.4%

안정적인 주가: SBS 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: SBS 의 주간 변동성( 5% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
19791,462Marcus Wolfingerwww.stratec.com

Stratec SE는 자회사와 함께 독일, 유럽 연합 및 전 세계에서 체외 진단 및 생명 과학 분야의 자동화 및 계측 솔루션을 설계 및 제조합니다. 임상 진단 및 생명공학 고객을 위한 자동화 분석기 시스템을 설계 및 제조하고, 진단 및 의료 애플리케이션을 위한 복잡한 소모품을 제공합니다. 이 회사는 이전에 스트라텍 바이오메디컬 AG로 알려졌으며 2018년 12월에 스트라텍 SE로 사명을 변경했습니다.

Stratec SE 기본 사항 요약

Stratec 의 수익과 매출은 시가총액과 어떻게 비교하나요?
SBS 기본 통계
시가총액€350.70m
수익(TTM)€10.01m
수익(TTM)€250.54m

35.0x

P/E 비율

1.4x

P/S 비율

SBS 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
SBS 손익 계산서(TTM)
수익€250.54m
수익 비용€182.78m
총 이익€67.75m
기타 비용€57.74m
수익€10.01m

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)0.82
총 마진27.04%
순이익 마진4.00%
부채/자본 비율67.0%

SBS 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

1.9%

현재 배당 수익률

67%

지급 비율